
Hurdle
Diagnostic Infrastructure to scale your healthcare solution
London, United Kingdom · Founded 2017 · $8.0M raised
- Headquarters
- London
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- hurdle.bio
- Total Funding
- $8.0M
- Last Round
- $8.0M Series AAug 2024
- Rounds
- 1
About
Hurdle is a UK-based diagnostics-as-a-service platform that provides end-to-end diagnostic infrastructure for healthcare providers, telehealth companies, and clinical research organizations. Its modular platform covers biomarker R&D, sample collection kits, lab testing, logistics, and digital patient experience, enabling businesses to launch and scale diagnostic solutions without building infrastructure from scratch.
Summary
Hurdle is a Biotech company based in London, United Kingdom, founded in 2017. It has raised $8.0M in total across 1 round, most recently a $8.0M Series A round in Aug 2024.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2024
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...